Breast Cancer Clinical Trials in Massachusetts

Showing 501-511 of 511 trials

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

NCT00093002

The purpose of this study is to evaluate fulvestrant in the preliminary stage of breast cancer treatment and assess the relationship between dose, exposure, degree of reduction in tumor markers, and efficacy in postmenopausal women with estrogen receptor positive disease.

Breast Cancer

AstraZeneca179 participantsStarted Jun 2004

Little Rock, Arkansas, United States • Boston, Massachusetts, United States • Winchester, Massachusetts, United States +28 more locations

COMPLETEDPhase 326 miles

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

NCT00002707

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if chemotherapy given before surgery is more effective with or without docetaxel given before or after surgery for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy using doxorubicin and cyclophosphamide with or without docetaxel in treating women who have stage II or stage III breast cancer.

Breast Cancer

NSABP Foundation Inc2,411 participantsStarted Dec 1995

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Greenbrae, California, United States +142 more locations

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Breast Cancer Trials in Other Cities

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

A Phase III Trial For Patients With Metastatic Breast Cancer

Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer

Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed

Other Conditions in Massachusetts